Cidofovir dihydrate is an injectable antiviral medication and a nucleotide analogue belonging to the phosphonate class, primarily indicated for the treatment of cytomegalovirus retinitis in patients with… Read more
Cidofovir dihydrate is an injectable antiviral medication and a nucleotide analogue belonging to the phosphonate class, primarily indicated for the treatment of cytomegalovirus retinitis in patients with AIDS and other severe viral infections. This category provides essential analytical tools, including reference standards for the cidofovir dihydrate API, as well as specific pharmacopeial and non-pharmacopeial impurities such as the R-enantiomer and related compound B. Laboratories utilize these high-quality materials, along with stable isotope labelled compounds, to support rigorous impurity profiling, method development, and validation protocols. By incorporating these validated reference materials into analytical workflows, researchers can ensure accurate identification and quantification of degradation products and synthesis by-products, ultimately maintaining the quality control standards required for pharmaceutical substances.